WMSA
KPTI icon

Weiss Multi-Strategy Advisers’s Karyopharm Therapeutics KPTI Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,803
Closed -$23K – 260
2023
Q4 		$23K Sell
1,803
-318
-15% -$4.29K ﹤0.01% 524
2023
Q3 		$43K Sell
2,121
-250
-11% -$5.61K ﹤0.01% 526
2023
Q2 		$64K Sell
2,371
-250
-10% -$10.8K ﹤0.01% 611
2023
Q1 		$153K Buy
2,621
+1,012
+63% +$50K ﹤0.01% 593
2022
Q4 		$82K Sell
1,609
-39
-2% -$2.7K ﹤0.01% 565
2022
Q3 		$135K Sell
1,648
-53
-3% -$3.96K ﹤0.01% 631
2022
Q2 		$115K Sell
1,701
-158
-8% -$14.5K ﹤0.01% 633
2022
Q1 		$205K Sell
1,859
-133
-7% -$16.6K ﹤0.01% 625
2021
Q4 		$192K Sell
1,992
-281
-12% -$28K ﹤0.01% 613
2021
Q3 		$198K Buy
2,273
+51
+2% +$5.29K ﹤0.01% 628
2021
Q2 		$344K Buy
2,222
+79
+4% +$11.5K 0.01% 588
2021
Q1 		$338K Buy
2,143
+470
+28% +$99K 0.01% 588
2020
Q4 		$388K Buy
1,673
+197
+13% +$45.6K 0.01% 597
2020
Q3 		$323K Buy
+1,476
New +$361K 0.01% 511
2020
Q2 		– Sell
-707
Closed -$204K – 584
2020
Q1 		$204K Sell
707
-293
-29% -$80.8K 0.01% 388
2019
Q4 		$288K Sell
1,000
-667
-40% -$145K ﹤0.01% 562
2019
Q3 		$241K Hold
1,667
– – ﹤0.01% 537
2019
Q2 		$150K Hold
1,667
– – ﹤0.01% 474
2019
Q1 		$146K Hold
1,667
– – ﹤0.01% 484
2018
Q4 		$234K Buy
1,667
+327
+24% +$55.2K 0.01% 406
2018
Q3 		$342K Buy
1,340
+7
+0.5% +$1.94K 0.01% 475
2018
Q2 		$340K Buy
+1,333
New +$330K 0.01% 506

Other funds holding KPTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's KPTI Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Karyopharm Therapeutics (KPTI) in Q1 2024, closing a stake of 1,803 shares — an estimated $23K sold.

Weiss Multi-Strategy Advisers first reported a position in KPTI in Q2 2018 and held it in 22 quarters. The position peaked at $388K in Q4 2020. 113 funds tracked by Wall St. Rank hold KPTI as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Karyopharm Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 1,803 Karyopharm Therapeutics shares in Q1 2024, an estimated $23K.
  • Weiss Multi-Strategy Advisers first reported a position in Karyopharm Therapeutics in Q2 2018 and held it in 22 quarters.
  • Weiss Multi-Strategy Advisers's Karyopharm Therapeutics position peaked at $388K in Q4 2020.
  • 113 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.